Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations. [electronic resource] by
- DeLeon, Thomas T
- Almquist, Daniel R
- Kipp, Benjamin R
- Langlais, Blake T
- Mangold, Aaron
- Winters, Jennifer L
- Kosiorek, Heidi E
- Joseph, Richard W
- Dronca, Roxana S
- Block, Matthew S
- McWilliams, Robert R
- Kottschade, Lisa A
- Rumilla, Kandelaria M
- Voss, Jesse S
- Seetharam, Mahesh
- Sekulic, Aleksandar
- Markovic, Svetomir N
- Bryce, Alan H
Producer: 20200623
In:
PloS one vol. 15
Availability: No items available.
|